Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K H Link

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
British Journal of Cancer|September 30, 2010
Adjuvant chemoradiotherapy of advanced resectable rectal cancer: results of a randomised trial comparing modulation of 5-fluorouracil with folinic acid or with interferon-αM Kornmann, L Staib, T Wiegel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 1996
Regional chemotherapy directed by individual chemosensitivity testing in vitro: a prospective decision-aiding trialK H Link, M Kornmann, G H Leder, et al.
British Journal of Cancer|December 1, 1996
CAM 17.1--a new diagnostic marker in pancreatic cancerF Gansauge, S Gansauge, N Parker, et al.
Langenbeck'S Archives of Surgery|September 30, 2004
Colon cancer: survival after curative surgeryK H Link, T A Sagban, M Mörschel, et al.
Swiss Surgery = Schweizer Chirurgie = Chirurgie Suisse = Chirurgia Svizzera|January 5, 2002
Surgery, radio- and chemotherapy for multimodal treatment of rectal cancerK H Link, L Staib, M Kornmann, et al.
British Journal of Cancer|February 23, 2012
Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trialA Tikidzhieva, A Benner, S Michel, et al.
Cancer Treatment Reviews|January 1, 1996
Quality assurance by specification and achievement of goals in palliative cancer treatmentF Porzsolt, A Wirth, R Mayer-Steinacker, et al.
Onkologie|December 1, 1984
[Isolated hyperthermic extremity perfusion with vindesine, dacarbazine and cisplatin in the treatment of malignant melanomas]K R Aigner, A Jungbluth, K H Link, et al.
Cancer|December 26, 2001
Regional chemotherapy of nonresectable colorectal liver metastases with mitoxantrone, 5-fluorouracil, folinic acid, and mitomycin C may prolong survivalK H Link, E Sunelaitis, M Kornmann, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 4, 2008
Prognostic factors influencing the survival of patients with colon cancer receiving adjuvant 5-FU treatmentM Kornmann, A Formentini, C Ette, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
British Journal of Cancer|September 30, 2010
Adjuvant chemoradiotherapy of advanced resectable rectal cancer: results of a randomised trial comparing modulation of 5-fluorouracil with folinic acid or with interferon-αM Kornmann, L Staib, T Wiegel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 1996
Regional chemotherapy directed by individual chemosensitivity testing in vitro: a prospective decision-aiding trialK H Link, M Kornmann, G H Leder, et al.
British Journal of Cancer|December 1, 1996
CAM 17.1--a new diagnostic marker in pancreatic cancerF Gansauge, S Gansauge, N Parker, et al.
Langenbeck'S Archives of Surgery|September 30, 2004
Colon cancer: survival after curative surgeryK H Link, T A Sagban, M Mörschel, et al.
Swiss Surgery = Schweizer Chirurgie = Chirurgie Suisse = Chirurgia Svizzera|January 5, 2002
Surgery, radio- and chemotherapy for multimodal treatment of rectal cancerK H Link, L Staib, M Kornmann, et al.
British Journal of Cancer|February 23, 2012
Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trialA Tikidzhieva, A Benner, S Michel, et al.
Cancer Treatment Reviews|January 1, 1996
Quality assurance by specification and achievement of goals in palliative cancer treatmentF Porzsolt, A Wirth, R Mayer-Steinacker, et al.
Onkologie|December 1, 1984
[Isolated hyperthermic extremity perfusion with vindesine, dacarbazine and cisplatin in the treatment of malignant melanomas]K R Aigner, A Jungbluth, K H Link, et al.
Cancer|December 26, 2001
Regional chemotherapy of nonresectable colorectal liver metastases with mitoxantrone, 5-fluorouracil, folinic acid, and mitomycin C may prolong survivalK H Link, E Sunelaitis, M Kornmann, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 4, 2008
Prognostic factors influencing the survival of patients with colon cancer receiving adjuvant 5-FU treatmentM Kornmann, A Formentini, C Ette, et al.
Pageof 8